BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ciclesonide (Alvesco) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ciclesonide (Alvesco)\, from ClinicalTria
 ls.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06589245-4614@assetmemo.bio
DTSTAMP:20261121T005632Z
DTSTART;VALUE=DATE:20270531
DTEND;VALUE=DATE:20270601
SUMMARY:ciclesonide (Alvesco): Phase 1 readout est. (NCT06589245)
DESCRIPTION:ciclesonide (Alvesco)\, phase 1.\nStudy: Inhaled Ciclesonide St
 udy in Preterm Infants\nEstimated primary completion: 31 May 2027. This is
  a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can
  move.\nDrug page: https://assetmemo.bio/drug/ciclesonide-alvesco#upcoming
 -events\nRegistry record: https://clinicaltrials.gov/study/NCT06589245
URL:https://assetmemo.bio/drug/ciclesonide-alvesco#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
